rs55705857

This is a intron variant variant in the CCDC26 gene.

GWAS Catalog Trait Associations (12)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

central nervous system cancer

Allele G
OR 3.60
p 1.0e-62
N 9,799
Large GWAS
European

brain attribute

van der Meer D et al. The genetic architecture of human cortical folding. Science Advances 7(51):eabj9446 (2021)
Allele G
OR 14.78
p 2.0e-49
N 33,748
Large GWAS
European

lymphocyte:monocyte ratio

Kachuri L et al. Genetic determinants of blood-cell traits influence susceptibility to childhood acute lymphoblastic leukemia. American Journal of Human Genetics 108(10):1823-1835 (2021)
Allele A
OR
p 1.0e-22
N 234,184
Large GWAS
European

cortical thickness

van der Meer D et al. The genetic architecture of human cortical folding. Science Advances 7(51):eabj9446 (2021)
Allele G
OR 7.94
p 2.0e-15
N 33,748
Large GWAS
European

cerebral cortex area attribute

van der Meer D et al. The genetic architecture of human cortical folding. Science Advances 7(51):eabj9446 (2021)
Allele G
OR 7.79
p 7.0e-15
N 33,748
Large GWAS
European

brain connectivity attribute

Allele A
OR 6.85
p 7.0e-12
N 30,810
Large GWAS
European

white matter integrity

Allele G
OR 0.14
p 3.0e-10
N 20,860
Major Consortium StudyLarge GWAS
European

mean fractional anisotropy measurement

Allele G
OR 0.13
p 1.0e-9
N 20,860
Major Consortium StudyLarge GWAS
European

ClinVar annotation

Risk Factor
1 submitter1 publication

Glioma susceptibility 7

View on ClinVar →

Research that mentions this SNP (2)

Age‐specific genome‐wide association study in glioblastoma identifies increased proportion of ‘lower grade glioma’‐like features associated with younger age
AssociationN=15,094Quinn T. Ostrom et al.(2018)· International Journal of Cancer

Age-stratified genome-wide association study of 4,512 glioblastoma cases and 10,582 controls identified age-specific genetic effects on disease susceptibility. SNPs at 7p11.2 (rs723527, rs11979158 near EGFR) showed increased association in older individuals (age 54+, OR=1.28-1.42), while a lower-grade glioma-associated SNP at 8q24.21 (rs55705857) was associated with younger diagnosis (age 18-53, OR=1.76, p=9.30×10−11). IDH1/2 mutations occurred in 15% of younger GBM cases versus 0.8-2.1% in older cases, suggesting many younger cases represent 'secondary GBM' with LGG-like features.

Traits studied:Age-at-diagnosis in glioblastomaGlioblastomaGlioma
ATG12 expression quantitative trait loci associated with head and neck squamous cell carcinoma risk in a Chinese Han population
AssociationN=1,056Xueyao Song et al.(2018)· Molecular Carcinogenesis

This study investigated the association of MGMT enhancer variant rs11016629 with glioma susceptibility and progression in 402 patients and 654 controls. The TG genotype was associated with increased glioma risk (OR=1.41, 95% CI 1.03-1.93, P=0.034), particularly in WHO grade IV tumors (OR=1.59, P=0.023). In patients who underwent gross total resection, carriers with TG/TT genotypes had worse progression-free survival (HR=2.66, 95% CI 1.23-5.79, P=0.014) compared to GG carriers.

Traits studied:GlioblastomaGliomaHigh-grade gliomaWHO grade IV glioma

About CCDC26

Implicated in brain cancer and high grade glioma. [provided by Alliance of Genome Resources, Jul 2025]

View all CCDC26 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…